Sonja Ständer - Search Results

Year	Number of Results
2002	5
2003	8
2004	3
2005	5
2006	7
2007	5
2008	11
2009	7
2010	9
2011	12
2012	9
2013	10
2014	8
2015	10
2016	16
2017	23
2018	20
2019	35
2020	17
2021	26
2022	31
2023	29
2024	34
2025	38
2026	26

1

Quick assessment of quality-of-life in itch: An exploratory validation of the 5-item pruritus life quality.

Zeidler C, Garcovich S, Bobko S, Legat FJ, Lvov A, Brenaut E, Reich A, Serra-Baldrich E, Misery L, Szepietowski JC, Dugas M, Aulenbacher F, Salameh P, Ständer S, Pereira MP. Zeidler C, et al. Among authors: stander s. J Dtsch Dermatol Ges. 2026 Jun 4. doi: 10.1111/ddg.70289. Online ahead of print. J Dtsch Dermatol Ges. 2026. PMID: 42244333

2

[Chronic prurigo: overview of pathophysiology, diagnosis, and treatment].

Witte F, Zeidler C, Ständer S. Witte F, et al. Among authors: stander s. Dermatologie (Heidelb). 2026 Jun 2. doi: 10.1007/s00105-026-05710-5. Online ahead of print. Dermatologie (Heidelb). 2026. PMID: 42228089 Review. German.

3

Mapping the network of persistent somatic symptoms across diseases: Cross-sectional and longitudinal analyses from the SOMACROSS research unit.

Strahl A, Maehder K, Toussaint A, Hasenbank N, Schramm C, Lohse AW, Shedden Mora M, Huber TB, Schneider SW, Ständer S, Nestoriuc Y, von dem Knesebeck O, Vettorazzi E, Zapf A, Löwe B. Strahl A, et al. Among authors: stander s. J Psychosom Res. 2026 May 22;209:112871. doi: 10.1016/j.jpsychores.2026.112871. Online ahead of print. J Psychosom Res. 2026. PMID: 42214192 Free article.

4

Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.

Ständer S, Yosipovitch G, Kwatra SG, Mendes-Bastos P, Tsai TF, Nakajima S, Praestgaard AH, Zahn J, Wiggins S. Ständer S, et al. Dermatol Ther (Heidelb). 2026 Jun;16(6):3189-3200. doi: 10.1007/s13555-026-01777-z. Epub 2026 May 13. Dermatol Ther (Heidelb). 2026. PMID: 42120670 Free PMC article.

5

Nickel(II) sulphate-induced allergic contact dermatitis as experimental tool to investigate inflammatory pruritus in humans.

Lukaschek K, Bali KK, Agelopoulos K, Kaplan M, Ständer S, Rukwied R, Weisshaar E. Lukaschek K, et al. Among authors: stander s. Front Allergy. 2026 Apr 22;7:1786200. doi: 10.3389/falgy.2026.1786200. eCollection 2026. Front Allergy. 2026. PMID: 42099893 Free PMC article.

6

Evaluation of itch intensity scales in atopic dermatitis: Differential measurement properties and associations with relevant cytokines.

Witte F, Wiegmann H, Teitge E, Westmeier J, Raker VK, Royeck S, Zeidler C, Agelopoulos K, Ständer S. Witte F, et al. Among authors: stander s. J Invest Dermatol. 2026 Apr 20:S0022-202X(26)01046-8. doi: 10.1016/j.jid.2026.04.005. Online ahead of print. J Invest Dermatol. 2026. PMID: 42019909 Free article.

7

Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo.

Royeck S, Olbrich H, Koschmieder S, Zeidler C, Witte F, Agelopoulos K, Wiegmann H, Storck M, Oehm JB, Ludwig RJ, Ständer S. Royeck S, et al. Among authors: stander s. J Dtsch Dermatol Ges. 2026 Apr 6. doi: 10.1111/ddg.70057. Online ahead of print. J Dtsch Dermatol Ges. 2026. PMID: 41937535

8

Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials.

Stander S, Zeidler C, Msihid J, Makhija M, Bansal A, Wiggins S, Zahn J, Thomas RB, Bahloul D. Stander S, et al. Dermatol Ther (Heidelb). 2026 Jun;16(6):2829-2835. doi: 10.1007/s13555-026-01692-3. Epub 2026 Apr 1. Dermatol Ther (Heidelb). 2026. PMID: 41922877 Free PMC article.

9

Dupilumab subgroup responder analysis: a post hoc analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis.

Kim BS, Kwatra SG, Yosipovitch G, Ständer S, Elmariah SB, Metz M, Tsai TF, Murota H, Gao XH, Hong HC, Bansal A, Makhija M, Thomas RB, Bahloul D, Zahn J, Wiggins S. Kim BS, et al. Among authors: stander s. J Dermatolog Treat. 2026 Dec;37(1):2626213. doi: 10.1080/09546634.2026.2626213. Epub 2026 Mar 11. J Dermatolog Treat. 2026. PMID: 41808464 Free article. Clinical Trial.

10

Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies.

Kwatra SG, Ständer S, Kim BS, Msihid J, Bansal A, Makhija M, Wiggins S, Zahn J, Thomas RB, Bahloul D. Kwatra SG, et al. Among authors: stander s. Dermatol Ther (Heidelb). 2026 Mar;16(3):1767-1778. doi: 10.1007/s13555-026-01674-5. Epub 2026 Mar 2. Dermatol Ther (Heidelb). 2026. PMID: 41772282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Results by year